Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases.
Papalexandri A, Stalika E, Iskas M, Karypidou M, Zerva P, Touloumenidou T, Tachynopoulou V, Batsis I, Papadaki T, Sakellari I, Anagnostopoulos A, Stamatopoulos K. Papalexandri A, et al. Among authors: zerva p. Bone Marrow Transplant. 2013 Sep;48(9):1260-1. doi: 10.1038/bmt.2013.40. Epub 2013 Apr 22. Bone Marrow Transplant. 2013. PMID: 23604008 No abstract available.
Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?
Papalexandri A, Karypidou M, Stalika E, Kotta K, Touloumenidou T, Zerva P, Paleta A, Mallouri D, Batsis I, Sakellari I, Kotsianidis I, Anagnostopoulos A, Hadzidimitriou A, Margaritis D, Stamatopoulos K. Papalexandri A, et al. Among authors: zerva p. Leuk Lymphoma. 2019 Jul;60(7):1685-1692. doi: 10.1080/10428194.2018.1543881. Epub 2019 Jan 17. Leuk Lymphoma. 2019. PMID: 30652530
Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia.
Gavriilaki E, Christodoulou I, Koravou EE, Paleta A, Koutra M, Zerva P, Touloumenidou T, Papalexandri A, Apostolou C, Klonizakis P, Anagnostopoulos A, Vlachaki E. Gavriilaki E, et al. Among authors: zerva p. Hemasphere. 2018 Oct;2(5):e58. doi: 10.1097/HS9.0000000000000058. Epub 2018 Oct 2. Hemasphere. 2018. PMID: 30887002 Free PMC article. No abstract available.
Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?
Papalexandri A, Saloum R, Touloumenidou T, Papathanasiou M, Lalayanni C, Baldoumi E, Demosthenous C, Zerva P, Koutra MG, Athanasiadou A, Anagnostopoulos A. Papalexandri A, et al. Among authors: zerva p. Hemasphere. 2018 Nov 12;2(6):e157. doi: 10.1097/HS9.0000000000000157. eCollection 2018 Dec. Hemasphere. 2018. PMID: 31723795 Free PMC article. No abstract available.
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes.
Papalexandri A, Gavriilaki E, Vardi A, Kotsiou N, Demosthenous C, Constantinou N, Touloumenidou T, Zerva P, Kika F, Iskas M, Batsis I, Mallouri D, Yannaki E, Anagnostopoulos A, Sakellari I. Papalexandri A, et al. Among authors: zerva p. Int J Mol Sci. 2023 Nov 7;24(22):16029. doi: 10.3390/ijms242216029. Int J Mol Sci. 2023. PMID: 38003218 Free PMC article.